Nantahala Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4M Buy
4,767,552
+1,370,253
+40% +$5M 0.61% 47
2026
Q1
$13.4M Buy
3,397,299
+980,910
+41% +$4.94M 0.49% 56
2025
Q4
$16.4M Buy
2,416,389
+949,823
+65% +$6.66M 0.54% 44
2025
Q3
$10.2M Buy
+1,466,566
New +$10.2M 0.36% 64
2023
Q2
Sell
-1,529,100
Closed -$5.21M 132
2023
Q1
$5.21M Buy
1,529,100
+381,576
+33% +$1.48M 0.4% 48
2022
Q4
$3.19M Buy
+1,147,524
New +$3.43M 0.21% 65

Other funds holding MDXG

Nantahala Capital Management's MDXG Position: Q2 2026 in Review

Nantahala Capital Management increased its MiMedx Group (MDXG) stake by 40% in Q2 2026, buying an estimated $5M and bringing the position to 4,767,552 shares worth $18.4M. The position accounts for 0.61% of the portfolio, ranked #47.

Nantahala Capital Management first reported a position in MDXG in Q4 2022 and has held it in 6 quarters since. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Nantahala Capital Management held 4,767,552 shares of MiMedx Group worth $18.4M as of Q2 2026.
  • Nantahala Capital Management bought 1,370,253 MiMedx Group shares in Q2 2026, an estimated $5M.
  • MiMedx Group made up 0.61% of Nantahala Capital Management's portfolio in Q2 2026, its #47 holding.
  • Nantahala Capital Management first reported a position in MiMedx Group in Q4 2022 and has held it in 6 quarters since.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.